- call +1-201-465-4211
- email sales@mrinsights.biz
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
Scope of the Report:
Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.
The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017.
The global Healthcare Nanotechnology market is valued at 160800 million USD in 2018 and is expected to reach 255500 million USD by the end of 2024, growing at a CAGR of 9.7% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Healthcare Nanotechnology.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Healthcare Nanotechnology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Healthcare Nanotechnology market by product type and applications/end industries.
Market Segment by Companies, this report covers
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Market Segment by Applications, can be divided into
Anticancer
CNS Product
Anti-infective
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Healthcare Nanotechnology Market Overview
1.1 Product Overview and Scope of Healthcare Nanotechnology
1.2 Classification of Healthcare Nanotechnology by Types
1.2.1 Global Healthcare Nanotechnology Revenue Comparison by Types (2019-2024)
1.2.2 Global Healthcare Nanotechnology Revenue Market Share by Types in 2018
1.2.3 Nanomedicine
1.2.4 Nano Medical Devices
1.2.5 Nano Diagnosis
1.2.6 Other
1.3 Global Healthcare Nanotechnology Market by Application
1.3.1 Global Healthcare Nanotechnology Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Other
1.4 Global Healthcare Nanotechnology Market by Regions
1.4.1 Global Healthcare Nanotechnology Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Healthcare Nanotechnology Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Healthcare Nanotechnology Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Healthcare Nanotechnology Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Healthcare Nanotechnology Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Healthcare Nanotechnology Status and Prospect (2014-2024)
1.5 Global Market Size of Healthcare Nanotechnology (2014-2024)
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Healthcare Nanotechnology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.2 Teva Pharmaceuticals
2.2.1 Business Overview
2.2.2 Healthcare Nanotechnology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Pharmaceuticals Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.3 Abbott
2.3.1 Business Overview
2.3.2 Healthcare Nanotechnology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.4 UCB
2.4.1 Business Overview
2.4.2 Healthcare Nanotechnology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 UCB Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.5 Roche
2.5.1 Business Overview
2.5.2 Healthcare Nanotechnology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.6 Celgene
2.6.1 Business Overview
2.6.2 Healthcare Nanotechnology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Celgene Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Healthcare Nanotechnology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.8 Merck & Co
2.8.1 Business Overview
2.8.2 Healthcare Nanotechnology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck & Co Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.9 Biogen
2.9.1 Business Overview
2.9.2 Healthcare Nanotechnology Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Biogen Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.10 Stryker
2.10.1 Business Overview
2.10.2 Healthcare Nanotechnology Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Stryker Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.11 Gilead Sciences
2.11.1 Business Overview
2.11.2 Healthcare Nanotechnology Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Gilead Sciences Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.12 Pfizer
2.12.1 Business Overview
2.12.2 Healthcare Nanotechnology Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Pfizer Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.13 3M Company
2.13.1 Business Overview
2.13.2 Healthcare Nanotechnology Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 3M Company Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.14 Johnson & Johnson
2.14.1 Business Overview
2.14.2 Healthcare Nanotechnology Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Johnson & Johnson Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.15 Smith & Nephew
2.15.1 Business Overview
2.15.2 Healthcare Nanotechnology Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Smith & Nephew Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.16 Leadiant Biosciences
2.16.1 Business Overview
2.16.2 Healthcare Nanotechnology Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Leadiant Biosciences Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.17 Kyowa Hakko Kirin
2.17.1 Business Overview
2.17.2 Healthcare Nanotechnology Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Kyowa Hakko Kirin Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.18 Shire
2.18.1 Business Overview
2.18.2 Healthcare Nanotechnology Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Shire Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.19 Ipsen
2.19.1 Business Overview
2.19.2 Healthcare Nanotechnology Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Ipsen Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.20 Endo International
2.20.1 Business Overview
2.20.2 Healthcare Nanotechnology Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Endo International Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2018)
3 Global Healthcare Nanotechnology Market Competition, by Players
3.1 Global Healthcare Nanotechnology Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Healthcare Nanotechnology Players Market Share
3.2.2 Top 10 Healthcare Nanotechnology Players Market Share
3.3 Market Competition Trend
4 Global Healthcare Nanotechnology Market Size by Regions
4.1 Global Healthcare Nanotechnology Revenue and Market Share by Regions
4.2 North America Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
4.3 Europe Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
4.5 South America Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
5 North America Healthcare Nanotechnology Revenue by Countries
5.1 North America Healthcare Nanotechnology Revenue by Countries (2014-2019)
5.2 USA Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
5.3 Canada Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
5.4 Mexico Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
6 Europe Healthcare Nanotechnology Revenue by Countries
6.1 Europe Healthcare Nanotechnology Revenue by Countries (2014-2019)
6.2 Germany Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
6.3 UK Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
6.4 France Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
6.5 Russia Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
6.6 Italy Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Healthcare Nanotechnology Revenue by Countries
7.1 Asia-Pacific Healthcare Nanotechnology Revenue by Countries (2014-2019)
7.2 China Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
7.3 Japan Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
7.4 Korea Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
7.5 India Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
8 South America Healthcare Nanotechnology Revenue by Countries
8.1 South America Healthcare Nanotechnology Revenue by Countries (2014-2019)
8.2 Brazil Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
8.3 Argentina Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
8.4 Colombia Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Healthcare Nanotechnology by Countries
9.1 Middle East and Africa Healthcare Nanotechnology Revenue by Countries (2014-2019)
9.2 Saudi Arabia Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
9.3 UAE Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
9.4 Egypt Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
9.5 Nigeria Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
9.6 South Africa Healthcare Nanotechnology Revenue and Growth Rate (2014-2019)
10 Global Healthcare Nanotechnology Market Segment by Type
10.1 Global Healthcare Nanotechnology Revenue and Market Share by Type (2014-2019)
10.2 Global Healthcare Nanotechnology Market Forecast by Type (2019-2024)
10.3 Nanomedicine Revenue Growth Rate (2014-2024)
10.4 Nano Medical Devices Revenue Growth Rate (2014-2024)
10.5 Nano Diagnosis Revenue Growth Rate (2014-2024)
10.6 Other Revenue Growth Rate (2014-2024)
11 Global Healthcare Nanotechnology Market Segment by Application
11.1 Global Healthcare Nanotechnology Revenue Market Share by Application (2014-2019)
11.2 Healthcare Nanotechnology Market Forecast by Application (2019-2024)
11.3 Anticancer Revenue Growth (2014-2019)
11.4 CNS Product Revenue Growth (2014-2019)
11.5 Anti-infective Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global Healthcare Nanotechnology Market Size Forecast (2019-2024)
12.1 Global Healthcare Nanotechnology Market Size Forecast (2019-2024)
12.2 Global Healthcare Nanotechnology Market Forecast by Regions (2019-2024)
12.3 North America Healthcare Nanotechnology Revenue Market Forecast (2019-2024)
12.4 Europe Healthcare Nanotechnology Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Healthcare Nanotechnology Revenue Market Forecast (2019-2024)
12.6 South America Healthcare Nanotechnology Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Healthcare Nanotechnology Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Healthcare Nanotechnology Picture
Table Product Specifications of Healthcare Nanotechnology
Table Global Healthcare Nanotechnology and Revenue (Million USD) Market S
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
